The Quantellect read.As of Nov 19, 2026, 13 active firms cover Imax Corp: 11 rate it Buy or better, 2 sit at Neutral, and 0 rate it Sell or worse, a buy consensus. Targets span $45.00 to $65.00, a moderate spread. The average target of $57.08 sits 22% above the current $46.82. The rating mix has stayed broadly stable, with Buy-side ratings edging up from 9 to 11 over recent months. On the fundamentals, the Street sees consensus EPS building from about $0.30 next quarter toward $2.27 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS13 active firms
Buy
Strong Buy00%
Buy1185%
Neutral215%
Sell00%
Strong Sell00%
Based on 13 active firms as of Nov 19, 2026 (365-day activity window).
12-MONTH PRICE TARGET
$57.08
+21.9% upside
Average target across 13 active firms as of Nov 19, 2026 vs $46.82 current
Highest Target$65.00
Average Target$57.08
Lowest Target$45.00
Detailed analyst forecasts for IMAX
Showing 1–12 of 12 named analysts shown · 13 active firms in the rating projection
As of Nov 19, 2026, 11 of 13 active firms rate IMAX a Buy (2 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
IMAX EPS & revenue forecast
EPS · NEXT QUARTER
$0.30
Range $0.29 – $0.32 · 5 analysts · +78% YoY
Next period, 5 analysts expect Imax Corp to earn $0.30 a share (range $0.29 – $0.32), versus $0.17 a year earlier. Full-year consensus is $3.00, growing to $2.27 the year after.
REVENUE · NEXT QUARTER
$98.7M
Range $88.9M – $107.6M · 5 analysts · +21% YoY
Revenue is expected to reach $98.7M (range $88.9M – $107.6M), +21.3% year-over-year. Full-year consensus is $489.0M, rising to $502.6M next year.
Top analysts covering Imax Corp
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on IMAX.
#1
PS
Patrick Sholl
Barrington Research · Rank #72
Buy
$50.00+6.8% to target
Overall win rate
45%
+ Follow
#2
David Karnovsky
JP Morgan · Rank #179
Buy
$58.00+23.9% to target
Overall win rate
43%
+ Follow
#3
Chad Beynon
Macquarie · Rank #378
Buy
$55.00+17.5% to target
Overall win rate
37%
+ Follow
#4
Mike Hickey
Benchmark · Rank #408
Buy
$60.00+28.2% to target
Overall win rate
39%
+ Follow
#5
Alicia Reese
Wedbush · Rank #446
Buy
$60.00+28.2% to target
Overall win rate
32%
+ Follow
IMAX stock forecast FAQ
What is IMAX's average 12-month price target?+
The 13 active firms with a live target average $57.08 for Imax Corp over the next 12 months, ranging from a $65.00 high to a $45.00 low, as of Nov 19, 2026.
Is IMAX stock a Buy, Sell or Neutral right now?+
The current consensus is Buy. Of the 13 active firms as of Nov 19, 2026, 11 rate it Buy or Strong Buy, 2 rate it Neutral, and 0 rate it Sell or Strong Sell.
What are the highest and lowest price targets for IMAX?+
The Street-high target is $65.00 (Rosenblatt), and the Street-low is $45.00 (Seaport Global). The average of all 13 active-firm targets is $57.08.
How many active Wall Street firms cover IMAX?+
13 active firms have a recognized rating on Imax Corp as of Nov 19, 2026, and 13 active firms carry a live 12-month price target.
Who is the most accurate analyst covering IMAX?+
Among analysts who currently cover IMAX, Patrick Sholl of Barrington Research has the strongest overall Quantellect track record (Rank #72). Their current call is Buy with a $50.00 target.
What is Imax Corp's projected EPS for next quarter?+
The consensus estimate is $0.30 per share (range $0.29 – $0.32) across 5 analysts. Full-year EPS is projected at $3.00, rising to $2.27 the following year.
How much revenue is Imax Corp expected to report next quarter?+
Consensus revenue is $98.7M (range $88.9M – $107.6M). Full-year revenue is projected at $489.0M, growing to $502.6M next year.
Have analysts been upgrading or downgrading IMAX lately?+
As of Nov 19, 2026, 11 of 13 active firms rate IMAX a Buy (2 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their IMAX calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.